Posted Aug. 29, 2014 at 9:57 a.m.

Premium Lock US funds another $2.4M for Ebola vaccine work at BioCryst

Published: 2014-08-29 09:57:00
Updated: 2014-08-29 09:57:00

Ebola virus     Ebola virus Image 1 of 3 · Next Image…

The National Institute of Allergy and Infectious Diseases has provided another $2.4 million in funding to Triangle-based BioCryst Pharmaceuticals for further development of a potential vaccine to treat Ebola. It's part of a global ramping up to fight the Ebola outbreak in West Africa....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders